Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Swertiamaroside
1. 17388-39-5
2. Swertiamarine
3. Swertiamaroside
4. Mls002473253
5. Chebi:9370
6. Chembl456138
7. (3s,4r,4ar)-4-ethenyl-4a-hydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,5,6-tetrahydropyrano[3,4-c]pyran-8-one
8. 4038595t7y
9. Ac1l9ctk
10. Unii-4038595t7y
11. 1h,3h-pyrano(3,4-c)pyran-1-one, 5-ethenyl-6-(beta-d-glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy-, (4ar,5r,6s)-
12. 1h,3h-pyrano[3,4-c]pyran-1-one, 5-ethenyl-6-(beta-d-glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy-, (4ar,5r,6s)-
13. Mfcd07783984
14. Swertamarin
15. Brn 0055278
16. Swertiamarin [mi]
17. Surecn422560
18. 4-19-00-02723 (beilstein Handbook Reference)
19. Schembl422560
20. Swertiamarin [who-dd]
21. Megxp0_000871
22. Acon1_000546
23. Swertiamarin, Analytical Standard
24. Dtxsid50169676
25. Hms2205k13
26. Hy-n0807
27. Zinc4098354
28. S3927
29. Akos015965365
30. Ac-8039
31. Ccg-268346
32. Swertiamarin, >=95% (lc/ms-elsd)
33. Ncgc00168975-01
34. Ncgc00168975-03
35. (3s,4r,4ar)-4a-hydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-vinyl-3,4,5,6-tetrahydropyrano[3,4-c]pyran-8-one
36. Bs-16249
37. Smr001397340
38. Cs-0009812
39. N1348
40. C09800
41. 388s395
42. A811580
43. Q-100208
44. Brd-k15387485-001-01-1
45. Q27108363
46. F0001-0632
47. (3s,4r,4ar)-4a-hydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-vinyl-3,4,5,6-tetrahydropyrano[3,4-c]pyran-8-one;swertiamarine
48. (4ar,5r,6s)-4a-hydroxy-6-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-5-vinyl-4,4a,5,6-tetrahydropyrano[3,4-c]pyran-1(3h)-one
49. 1h,3h-pyrano(3,4-c)pyran-1-one, 5-ethenyl-6-(.beta.-d-glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy-, (4ar,5r,6s)-
50. 1h,3h-pyrano(3,4-c)pyran-1-one, 5-ethenyl-6-(beta-d-glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy-, (4ar-(4aalpha,5beta,6alpha))-
Molecular Weight | 374.34 g/mol |
---|---|
Molecular Formula | C16H22O10 |
XLogP3 | -2 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 4 |
Exact Mass | 374.12129689 g/mol |
Monoisotopic Mass | 374.12129689 g/mol |
Topological Polar Surface Area | 155 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 592 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?